Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients

Part of paid clinical trials in New York, New York.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT03546387
Status
Recruiting
Apply to this trial

Conditions

  • Pediatric Retinoblastoma
  • Retinoblastoma

Eligibility Criteria

Sex
ALL
Age
6 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) — OTHER
    the WISC-V assessment produces a Full Scale IQ (FSIQ) used for primary power consideration in this study. The FSIQ is the most comprehensive global ability score on the WISC-V, and it has been conventionally reported and interpreted as an estimation of overall intellectual ability
  • California Verbal Learning Test, Children's Version — OTHER
    Used to assess verbal learning and memory in children and adolescents
  • Beery Developmental Test of Visual Motor Integration, 6th edition — OTHER
    Helps assess visual-motor skills in children and adults.
  • Grooved Pegboard Test — OTHER
    Measures dexterity
  • Behavior Assessment System for Children/Parent Report — OTHER
    The Behavior Assessment System for Children/Parent Report is a questionnaire that assesses the social-emotional and behavioral functioning (e.g., anxiety, depression, attention, hyperactivity, adaptability, leadership, social skills, etc.) in children between the ages of 2 and 22 years, and is available in English and Spanish.

Study Details

The purpose of this study is to see if there is a difference between the development of the brain (neurodevelopment) in children who have been treated for retinoblastoma with multiple anesthetic exposures, compared with brain development in children who have never had anesthesia.

Key Dates

Start date
May 7, 2018
Status verified
Jun 2026
Primary completion
May 7, 2027
Completion
May 7, 2027

Study Design

Enrollment
75 participants (estimated)

Primary Outcome Measure

Comparing scores in neuropsychological testing results [ Time Frame: 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Vittoria Arslan Carlon, MD
212-639-2680

Find similar trials in New York, NY

By research site
Memorial Sloan Kettering Cancer Center· New York, NY

Related Studies